Analyzes seized black market products promoted as growth-enhancing substances. LC-HRMS identified modified GHRPs, including glycine-modified analogs of GHRP-2 and ipamorelin, suggesting manufacturers alter peptide structures to evade anti-doping detection while maintaining biological activity.
Krug, Oliver; Thomas, Andreas; Malerød-Fjeld, Helle; Dehnes, Yvette; Laussmann, Tim; Feldmann, Ingo; Sickmann, Albert; Thevis, Mario